Towards the Development of Multiplexed Cellular Therapies: The Promise of iPSC Derived T-cell Products
Time: 4:00 pm
day: Day 1 - Track A - Post Lunch
Details:
- Design of effective allogeneic cell therapies requires multiplexed engineering.
- Clinical success in solid tumor settings will require multiple mechanisms of action.
- Stem Cell derived products enable identification and expansion of engineered products without deleterious off target damage.
- Control of Notch signaling is critical for lineage commitment and differentiation potential of developing T-cells
